Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Hypomagnesemia-related magnesium supplementation and its association with healthcare burden and adverse outcomes in patients with heart failure: a population-based study

EF 2022-23

Résumé
In a current population-based, retrospective cohort study, using data from the databases of Alberta Health and Alberta Health Services for patients who have been hospitalized for heart failure (HF) we aim to investigate the amount of serum magnesium testing and intravenous (IV) magnesium supplementation in HF patients in addition to the association between magnesium supplementation and HF patient outcomes. We are also interested in determining the relationship between the results of a diagnostic test and IV magnesium supplementation as well as the burden of health care resources of magnesium related HF treatment. The databases described were chosen due to their representative and descriptive information on sex and demographics which will allow us to explore the consequences of treatment of hypomagnesemia, which is low magnesium levels, equally among diverse groups without restrictive inclusion criteria. We will use a number of statistical tools such as descriptive statistics, Kaplan Meier curves, and Cox proportional hazards regression models adjusted for age, sex, and previous comorbidities to inform our objectives. Finally, we will report the findings of our study through a number of mediums such as abstracts, manuscripts and presentations which will be presented in conferences, journals, and social media. In this way we will engage health policy experts, clinical staff, patients, and community members in our findings. These findings may indicate the need for more magnesium testing and replacement therapies, or, they may indicate that testing and replacement are an unnecessary cost burden which reduces resources for more effective therapies. In either case the information collected by this study will have a vested benefit for patients and the health system as a whole.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
485924
Name
Margaryan Robert
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Hypomagnesemia-related magnesium supplementation and its association with healthcare burden and adverse outcomes in patients with heart failure: a population-based study
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Heart Failure; Alberta; Health Economics; Hypomagnesemia; Intravenous; Laboratory Testing; Magnesium Replacement; Population-Based; Retrospective Cohort; Treatment Guidelines
Abstract
In a current population-based, retrospective cohort study, using data from the databases of Alberta Health and Alberta Health Services for patients who have been hospitalized for heart failure (HF) we aim to investigate the amount of serum magnesium testing and intravenous (IV) magnesium supplementation in HF patients in addition to the association between magnesium supplementation and HF patient outcomes. We are also interested in determining the relationship between the results of a diagnostic test and IV magnesium supplementation as well as the burden of health care resources of magnesium related HF treatment. The databases described were chosen due to their representative and descriptive information on sex and demographics which will allow us to explore the consequences of treatment of hypomagnesemia, which is low magnesium levels, equally among diverse groups without restrictive inclusion criteria. We will use a number of statistical tools such as descriptive statistics, Kaplan Meier curves, and Cox proportional hazards regression models adjusted for age, sex, and previous comorbidities to inform our objectives. Finally, we will report the findings of our study through a number of mediums such as abstracts, manuscripts and presentations which will be presented in conferences, journals, and social media. In this way we will engage health policy experts, clinical staff, patients, and community members in our findings. These findings may indicate the need for more magnesium testing and replacement therapies, or, they may indicate that testing and replacement are an unnecessary cost burden which reduces resources for more effective therapies. In either case the information collected by this study will have a vested benefit for patients and the health system as a whole.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Margaryan, Robert
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~